Dashboard
1
With a growth in Net Profit of 132.1%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 2 consecutive quarters
- ROCE(HY) Highest at 7.01%
- RAW MATERIAL COST(Y) Fallen by -5.73% (YoY)
- NET SALES(Q) Highest at CNY 973.24 MM
2
With ROE of 8.73%, it has a attractive valuation with a 1.33 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
CNY 6,330 Million (Mid Cap)
19.00
NA
4.06%
-0.25
8.73%
1.64
Revenue and Profits:
Net Sales:
659 Million
(Quarterly Results - Jun 2026)
Net Profit:
128 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.93%
0%
4.93%
6 Months
-2.41%
0%
-2.41%
1 Year
-14.11%
0%
-14.11%
2 Years
30.08%
0%
30.08%
3 Years
-21.55%
0%
-21.55%
4 Years
4.28%
0%
4.28%
5 Years
-2.29%
0%
-2.29%
Jiuzhitang Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-8.94%
EBIT Growth (5y)
-5.02%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.61
Tax Ratio
15.77%
Dividend Payout Ratio
114.07%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.64%
ROE (avg)
7.04%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
1.68
EV to EBIT
16.62
EV to EBITDA
12.94
EV to Capital Employed
1.90
EV to Sales
2.32
PEG Ratio
0.26
Dividend Yield
3.96%
ROCE (Latest)
11.42%
ROE (Latest)
8.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
659.00
973.20
-32.29%
Operating Profit (PBDIT) excl Other Income
163.50
262.80
-37.79%
Interest
0.50
0.40
25.00%
Exceptional Items
0.70
0.50
40.00%
Consolidate Net Profit
127.60
200.60
-36.39%
Operating Profit Margin (Excl OI)
196.10%
234.80%
-3.87%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is -32.29% vs 61.71% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is -36.39% vs 114.32% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,206.80
2,351.00
-6.13%
Operating Profit (PBDIT) excl Other Income
373.60
294.50
26.86%
Interest
1.60
2.80
-42.86%
Exceptional Items
0.40
0.00
Consolidate Net Profit
259.60
215.20
20.63%
Operating Profit Margin (Excl OI)
112.00%
73.20%
3.88%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -6.13% vs -19.95% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 20.63% vs -27.25% in Dec 2024
About Jiuzhitang Co., Ltd. 
Jiuzhitang Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






